States of Matter Through Fun Experiments
Dive into the world of solids, liquids, and gases with engaging activities like shaking jars of beads to represent different molecular movements and conducting experiments with Alka Seltzer tablets in water. Discover how matter transitions between states and observe the fascinating reactions that occur. Engage students in hands-on learning experiences to deepen their understanding of fundamental concepts in chemistry and physics.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
"A Novel Epigenetic-Based Approach to Type 2 Diabetes Management: Development and Evaluation of the GLX 10 Vaccine" Sherif Hesen Mohamed s.salah
Type 2 diabetes (T2D) and obesity are two of the most challenging public health problems of our time. Therefore, understanding the molecular mechanisms that contribute to these complex metabolic disorders is essential.
An underlying pathophysiological condition of T2D and obesity is insulin resistance (IR), a reduced biological response to insulin in peripheral tissues such as the liver, adipose tissue, and skeletal muscle. Many factors contribute to IR, including lifestyle variables such as a high-fat diet physical inactivity Genetics impaired mitochondrial function
Diabetes can significantly impact a patient's quality of life even with medications. Daily management burden: Patients need to monitor blood sugar levels, take medications, and carefully plan meals and activities. Dietary restrictions: Limiting certain foods and constantly counting carbohydrates can be frustrating and socially limiting. Physical Emotional toll: Anxiety, depression, and diabetes distress are common due to the constant need for self-management. Financial strain: Ongoing costs for medications, supplies, and medical visits can be significant. Fatigue and energy fluctuations: Blood sugar changes can affect energy levels and overall well- being. Increased health risks: Higher susceptibility to infections and slower wound healing. complications: Even with treatment, diabetes can lead to issues like neuropathy, vision problems, and increased risk of cardiovascular disease.
WHILE CONVENTIONAL THERAPIES FOR T2DM FOCUS ON CONTROLLING BLOOD GLUCOSE LEVELS THROUGH PHARMACOLOGICAL AGENTS SUCH AS: ORAL HYPOGLYCEMIC DRUGS INSULIN THESE TREATMENTS DO NOT ADDRESS THE UNDERLYING MITOCHONDRIAL DYSFUNCTION THAT DRIVES DISEASE PROGRESSION.
Mitochondria are double-membrane organelles found in almost all eukaryotic cells. They engage in several functions in the cell including regulation of: calcium homeostasis redox status cell growth and death adenosine triphosphate (ATP) production, Mitochondria provide over 90% of ATP required for cell metabolism
Mitochondria, the powerhouse of the cell, are responsible for energy production through oxidative phosphorylation. However, in individuals with T2DM, mitochondrial dysfunction has been strongly implicated in the disruption of cellular energy metabolism, insulin resistance, and glucose homeostasis.
It is well established that impaired mitochondria structure and function occur in insulin-resistant skeletal muscle volunteers with T2D or obesity. Therefore, it could be hypothesized that the mitochondrial abnormalities are due to epigenetic regulation of mitochondrial and nuclear-encoded genes that code for mitochondrial structure and function
Epigenetic is a stably heritable phenotype and reversible trait resulting from certain changes in gene expression that do not alter the underlying DNA sequence but modifies it, epigenetic modifications do not occur independently but rather crosstalk with and regulate one another to create an epigenetic profile, which changes the function of the genome (gene expression) by altering the chromatin structure The process of gene silencing by DNA methylation is required for critical biological processes
Hypermethylation other studies successfully identified the presence of mtDNA methylation, particularly in the mitochondrial displacement loop (D-loop) region fig1., relating it to changes in both mtDNA gene transcription and mitochondrial replication Figure 1.
Mitochondrial dysfunction has been strongly implicated in the disruption of cellular energy metabolism, insulin resistance, and glucose homeostasis. disrupt the normal function of mtDNA, reducing ATP production and exacerbating insulin resistance.
the persistence of this disease is due to the vicious circle that may be initialized by the increased mtDNA methylation level which may collapse the MMP, then the dysfunction of mitochondria may reduce the production of AKG which is essential for mtDNA demethylation; AKG exhaustion may exacerbate mtDNA hypermethylation resulting in a vicious circle that is associated with a reduction in the mtDNA copy number due to increased D-loop methylation levels in diabetic individuals. Figure 2.
The novel anti-diabetic Type 2 vaccine presented in this study represents a groundbreaking therapeutic approach, targeting the root cause of mitochondrial dysfunction in T2DM. By delivering a cocktail of epigenetic modulators, the vaccine aims hypermethylation, restore function, and improve overall metabolic health Preclinical studies demonstrated that the vaccine effectively breaks the vicious cycle of mtDNA hypermethylation dysfunction, while early clinical trials have shown promising results in metabolism and overall health in T2DM patients to reverse mtDNA mitochondrial and mitochondrial improving glucose This presentation will explore the development of the vaccine, its mode of action, and its potential to transform the treatment of type 2 diabetes by targeting mitochondrial dysfunction at the molecular level.
Mechanism of Action and Epigenetic Modulation The novel mechanism of the GLX 10 vaccine represents a significant leap forward in diabetes management. The vaccine targets the mitochondrial displacement loop (D-loop), a crucial region involved in mtDNA replication and transcription. Hyper-methylation of the D-loop has been implicated in mitochondrial dysfunction, reducing mitochondrial membrane potential (MMP) and ATP production, which are critical for cellular energy metabolism as described in Figure 1. This dysfunction further depletes - ketoglutarate (AKG), hypermethylation, perpetuating a cycle of metabolic decline and causing mitochondrial fragmentation. exacerbating mtDNA
GLX10 GLX10 MODULATORS MODULATORS The GLX 10 vaccine aims to disrupt this cycle by delivering epigenetic modulators that demethylate the D-loop region to restore the normal mtDNA copy numbers and gene expression mitochondria to produce the proteins and enzymes necessary for efficient ETC function to stabilize the MMP as shown in Figure 2. enabling the Figure 3.
GLX 10 Vaccine also mitigates the effects of metabolic memory phenomenon due to the enhancement of ATP production, reduction of reactive oxygen stabilization of mitochondrial membrane potential (MMP) that will eventually alleviate the physical and psychological fatigue associated with diabetes, thereby improving both quality of life and long-term health outcomes. species(ROS) and Figure 4.
